Art

J-GLOBAL ID：201802268133388632   Reference number：18A1369888

Clinical effect of long-term administration of tolvaptan in patients with heart failure and chronic kidney disease

心不全および慢性腎臓病患者におけるトルバプタン長期投与の臨床効果

Author (7)： Ono Yohei (Department of Cardiology, Fujioka General Hospital) ,  Takamatsu Hiroto (Department of Cardiology, Fujioka General Hospital) ,  Inoue Masahiro (Department of Cardiology, Fujioka General Hospital) ,  Mabuchi Yukio (Department of Cardiology, Fujioka General Hospital) ,  Ueda Tetsuya (Department of Cardiology, Fujioka General Hospital) ,  Suzuki Tadashi (Department of Cardiology, Fujioka General Hospital) ,  Kurabayashi Masahiko (Gunma University Hospital, Department of Cardiovascular Medicine,)
Material： Drug Discoveries & Therapeutics  (DD & T)
Volume： 12  Issue： 3  Page： 154-160(J-STAGE)  Publication year： 2018 
JST Material Number： F1177A  ISSN： 1881-7831  CODEN： DDTRBX  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *diuretic ,...
Semi thesaurus term： eGFR ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1369888&from=J-GLOBAL&jstjournalNo=F1177A") }}

Author keywords (3)： Heart failure treatment ,  diuretic ,  renal dysfunction

JST classification (3)： Clinical application of drugs acting on urinary system  (GW11020C) ,  Drug therapy(=pharmacotherapy)for cardiovascular system diseases  (GJ05020M) ,  Drug therapy(=pharmacotherapy)for urogenital diseases  (GM05020V)

Substance index (1)： OPC-41061

Reference (30)：

• 1. Chen HH, Redfield MM, Nordstrom LJ, Cataliotti A, Burnett JC Jr. AngiotensinII AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure. Am J Physiol Renal Physiol. 2003; 284:F1115-1119.
• 2. Gottlieb SS, Brater DC, Thomas I, Havranek E, Bourge R, Goldman S, Dyer F, GomezM, Bennett D, Ticho B, Beckman E, Abraham WT. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation. 2002; 105:1348-1353.
• 3. Vallon V. Tubuloglomerular feedback and the control of glomerular filtration rate. News Physiol Sci. 2003; 18:169-174.
• 4. Cooper HA, Dries DL, Davis CE, Shen YL, Domanski MJ. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation. 1999; 100:1311-1315.
• 5. Domanski M, Norman J, Pitt B, Haigney M, Hanlon S, Peyster E. Studies of Left Ventricular Dysfunction. Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol. 2003; 42:705-708.

Terms in the title (6)： 心不全 ,  慢性 ,  腎臓病患者 ,  トルバプタン ,  長期投与 ,  臨床効果